City
Epaper

AstraZeneca Covid vaccine protection may last a lifetime: Study

By IANS | Updated: July 16, 2021 18:45 IST

New Delhi, July 16 The Oxford-AstraZeneca jab gives powerful protection that may last a whole lifetime, a new ...

Open in App

New Delhi, July 16 The Oxford-AstraZeneca jab gives powerful protection that may last a whole lifetime, a new study has found.

Apart from generating virus-busting antibodies, the vaccine also creates "training camps" in the body for search-and-destroy T-cells which can kill even the new variants, The Sun, UK, reported.

It means the body can continue making these vital cells long after the antibodies have waned, as possibly for the rest of your life, it said.

Scientists from Oxford, the UK, and Switzerland, writing in the journal ‘Nature', said that T-cell protection is a "key feature" of adenovirus vaccines like the Oxford and J&J jabs.

As per the report, researcher Burkhard Ludewig from Cantonal Hospital in Switzerland said: "The T-cells that come from these cellular training camps appear to have a very high level of ‘fitness'.

"Adenoviruses have co-evolved with humans over a very long time, and learned a lot about the human immune system in the process.

"Viruses are always the best teachers, and here they have taught us an important lesson about how best to boost killer T-cell responses.

"Hopefully we can put this to good use in designing new vaccines targeting other diseases like TB, HIV, hepatitis C and cancer."

The researchers found that adenoviruses are able to get into long-lived tissue cells, known as fibroblastic reticular cells, which act as "training grounds" for T-cells.

Previous studies have shown that the Oxford jab is more effective in generating T-cells than mRNA vaccines like Pfizer and Moderna.

T-cell levels are difficult to measure, but the new study gives hope that they may last a lifetime, the report said.

Paul Klenerman from the Nuffield Department of Medicine at Oxford said: "Millions of people have received adenovirus vaccines around the world. The ultimate goal with these vaccines is the induction of long-term immune system protection using both antibodies and T-cells.

"This research helps us to understand more on the process of vaccination, and why the effects on killer T-cells are so prolonged."

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Johnson & JohnsonBurkhard ludewigPaul klenermanNew DelhiOxfordThe sunThe new delhi municipal councilDelhi south-west
Open in App

Related Stories

Social ViralViral Video: Snake Found Inside Train Toilet, Internet Reacts

EntertainmentAjith Kumar Injured in Fan Frenzy After Padma Bhushan Award Ceremony, Actor Hospitalized In Chennai

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

NationalNew Delhi Railway Station Sees ‘Stampede-Like’ Chaos Due to Train Delays (Watch)

NationalAmit Shah Reviews Delhi’s Law & Order Situation, Says Illegal Intruders Will Be Identified and Deported

Health Realted Stories

HealthMother-to-child HIV transmission declined in India by 84 pc from 2010-2024: Anupriya Patel

HealthStudy claims beetroot juice can lower blood pressure in elderly

HealthLifestyle solution might yield better results for Indians with obesity risk, says study

Health48 projects approved to avoid disruption in supply of critical active pharma ingredients

HealthDrugs and pharmaceuticals export up 92 pc in last 6 fiscals: Minister